Polmed Research Inc. has been participating in pharmaceutical clinical trials since 1988. These include Phase III, Phase IV, post-marketing and observational studies as well as investigator-initiated trials.
Diseases under study include osteoporosis (OP), osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis(AS) and fibromyalgia.
Polmed Research is able to provide assistance to your clinical trials with the following:
- Sub-Investigator
- Study Coordinator
- Study Start Up
Dr. Wojciech Olszynski has been the primary investigator for well over 100 clinical trials and has most recently been a Sub-Investigator for trials conducted by his rheumatology colleagues.
Of particular note, Dr. Olszynski was an Investigator and Director for the Canadian Multicentre Osteoporosis Study (CaMos). This was a ten-year study, with over 10,000 patients, conducted in multiple sites across Canada. The purpose of the study was to assess the burden of osteoporosis and fractures on Canadian males and females, to identify risk factors leading to prevention and improved diagnosis, and to assess the health and economic consequences of osteoporosis and fractures.
The research manager, Stephanie Grzybowski, has been working in clinical trials since 1994. She has had training in specimen collection and handling, joint assessments, assessments for RA, PsA and AS, as well as bone density testing. In addition to the rheumatology trials, she has assisted with gynecology trials and a flu trial.
Stephanie has extensive experience in the study start-up process including preparation of regulatory documents, ethics submissions and renewals, contracts and budget negotiations as well as coordinating patient visits.
Polmed also has a back-up coordinator, Jenelle Taylor, with experience in specimen collection and handling and coordinating patient visits.
Please contact Stephanie at (306)933-2665 or osteo.centre@sasktel.net for further information on how we can be of assistance with your clinical trial.